The final, formatted version of the article will be published soon.
CASE REPORT article
Front. Genet.
Sec. Genetics of Common and Rare Diseases
Volume 15 - 2024 |
doi: 10.3389/fgene.2024.1522204
Ar ticle Type: Case Repor t Identification of a Novel SPTB Gene Splicing Mutation in Her editar y Spher ocytosis: A Case Repor t and Diagnostic Insights
Provisionally accepted- Chongqing Medical and Pharmaceutical College, Chongqing, China
Abstr act: [Backgr ound] Hereditary spherocytosis (HS) is a group of genetically heterogeneous hereditary hemolytic disorders characterized by anemia, splenomegaly, jaundice, reticulocytosis, and spherical red blood cells on peripheral blood smears.Mutations in key genes, including SPTB, ANK1, SLC4A1, SPTA1, and EPB42, are commonly implicated in HS. [Case Pr esentation] we report the case of a 22-year-old female presenting with anemia, jaundice, and a family history of splenectomy.Laboratory investigations revealed hemolytic anemia, elevated bilirubin levels, and peripheral blood smear findings consistent with HS. Genetic testing identified a novel SPTB gene splicing mutation (NM_001355436.2: c.1645-1G>A), inherited maternally, which is predicted to disrupt normal RNA splicing and protein synthesis. [Discussion] the identified SPTB mutation expands the known mutation spectrum of the SPTB gene and highlights its role in the pathogenesis of HS. Clinical findings, combined with genetic analysis, confirmed the diagnosis of HS and underscored the importance of comprehensive molecular testing for accurate diagnosis, especially in patients with a strong family history. [Conclusion] this case emphasizes the utility of genetic testing in diagnosing hereditary spherocytosis, particularly for novel gene mutations. Early and accurate molecular diagnosis facilitates better clinical management, family counseling, and treatment decisions for patients with HS.
Keywords: Hereditary spherocytosis, novel SPTB gene, Mutation, hemolytic anemia, Splenomegaly, Jaundice
Received: 25 Nov 2024; Accepted: 31 Dec 2024.
Copyright: © 2024 Liu, Zhang, Li, Zhang, Wang, Li, Liu, Li, He and Tang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yongsheng Liu, Chongqing Medical and Pharmaceutical College, Chongqing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.